Pfizer Inc. (NYSE:PFE) announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the…
Tag:
Pfizer
-
-
Global MarketMerger / AcquisitionPfizer
Pfizer to Acquire Global Blood Therapeutics in $5.4bn Deal
by adminSummary : Through the acquisition of Global Blood Therapeutics, Pfizer aims to enhance its presence…
-
Merger / AcquisitionPfizer
Pfizer Acquire ReViral for $ 525 Millon and its Respiratory Syncytial Virus Therapeutic Candidates Sisunatovir
by adminSynopsis : Under the terms of the agreement, Pfizer will acquire ReViral for a total…
-
Covid DrugsPfizer and BioNTech
Pfizer and BioNTech receive expanded U.S. emergency use authorization for an additional COVID-19 vaccine booster in individuals aged 50 years and older
by adminSummary: Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S.…
-
Covid DrugsPfizer
Pfizer and BioNTech aubmit for U.S. Emergency Use Authorization of an additional booster dose of their COVID-19 vaccine for older adults
by adminSummary : Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced the companies have…
-
Synopsis : Pfizer Inc. (NYSE: PFE) Pfizer stands with the unified global community across the…
-
Pfizer
Phase 3 CLOVER Trial for Pfizer’s Investigational Clostridioides Difficile Vaccine Indicates Strong Potential Effect in Reducing Duration and Severity of Disease Based on Secondary Endpoints
by adminSummary : Pre-specified secondary endpoint showed 0-11 vaccine to placebo case split for medically attended…
-
Patent infringementPatentsPfizerWest-Coast Pharmaceutical works Ltd
Pfizer Inc filed a Patent Infringement suit against West-Coast Pharmaceutical works Ltd.
by adminSummary : Pfizer Inc. (plaintiff) filed a patent infringement suit against West-Coast Pharmaceutical works Ltd. …
-
ChemIntelligenceGlobal Market
First study to show waning effectiveness of 3rd dose of mRNA vaccines
by adminSummary : A nationwide study from the U.S. Centers for Disease Control and Prevention (CDC)…
-
Global MarketPAXLOVIDPfizer
After Watershed Year, Pfizer Expects Revenue to Top $98B in ’22
by adminSummary : Pfizer Chief Executive Officer Albert Bourla called 2021 a watershed year for the…
Newer Posts